testatina
The “Advanced Therapies” section aims at providing scientific and legislative information on new medicinal products. The main objective is to streamline and better secure access to advanced therapies for patients improving research, development and authorization procedures for genic therapy, somatic cell therapy and tissue engineering products.

In recent years, the science has witnessed the development of promising genic and cell approaches aimed at preventing and treating diseases and disorders of the human body such as cancer, diabetes, Parkinson's disease, hereditary diseases and other neurodegenerative pathologies. To date, experiments on these genic and cell products seem to be very promising and include treatments for skin, cartilage and bone pathologies and lesions.
Living somatic cells used in patients are either autologous (the donor and recipient are the same person), allogenic (the donor and recipient are two different people) or xenogenic (the donor's cells come from animals). These cells have undergone substantial manipulation to achieve a given therapeutic, diagnostic or preventive effect (with metabolic, pharmacological or immunological means).
 
The “Advanced Therapies” section is managed by the three institutional partners, namely the ISS (Italian Higher Institute for Health), CNT (Italian National Transplantation Agency) and AIFA (Italian National Pharmaceuticals Agency), and it belongs to the ITC-E2 Project promoted by the Region of Sicily and ISMETT.

Latest news

25/6/2010
Granfondo, in bici per la vita!

There are no translations available

Si terrà in Sicilia la 7ª edizione della Granfondo Ciclistica dei Trapiantati, organizzata dall’Associazione “Amici del trapianto di fegato” di Bergamo. La Granfondo è una manifestazione ciclistica non competitiva che ha l’obiettivo di promuovere la donazione degli organi e lo sviluppo della ricerca. Al giro ciclistico, che si svolgerà l’ultima settimana di settembre 2010, prenderanno parte pazienti sottoposti a trapianto che sono oggi di nuovo in grado di vivere una vita normale.

La Granfondo, che prevede come tappe: Palermo, Trapani, Sciacca, Caltanissetta, Catania e Messina, avrà inizio lunedì 27 settembre e si concluderà venerdì 1 ottobre. Il giro ciclistico, dopo la cerimonia di apertura e l’incontro con gli alunni del Liceo Garibaldi di Palermo, partirà dal piazzale ISMETT e si dirigerà verso le altre tappe della manifestazione.

>>Read more...

21/8/2009
1 Regenerative Medicine / Tissue Engineering Fellow

UPMC Italy is seeking an outstanding candidate for its Fellowship in Tissue Engineering, funded within a collaborative research program directed by Professor Ranieri Cancedda and recently established at ISMETT, in collaboration with the McGowan Institute for Regenerative Medicine of the University of Pittsburgh and the Regenerative Medicine Laboratory of the University of Genoa and of the National Institute for Cancer Research of Genoa. The selected candidate will contribute to the development of innovative cell therapy and tissue engineering products for the repair/regeneration of skeletal tissues (cartilage and bone), see to the implementation of suitable biomaterials to be adopted as scaffold and cell carriers and, in the case of bone, to the use of growth factors and bioactive molecules to support angiogenesis and vascularization of the newly formed tissue.
Enclosed is the call for applications

>>Read more...

Visualization of the site